Keppra Caution For Usage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Caution For Usage

Use and Handling: KEPPRA 100 mg/ml concentrate for solution for infusion: Table as follows presents the recommended preparation and administration of Keppra concentrate for solution for infusion to achieve a total daily dose of 500 mg, 1000 mg, 2000 mg, or 3000 mg in two divided doses. (See Table 4.)

Click on icon to see table/diagram/image

This medicinal product is for single use only, any unused solution should be discarded.
Keppra concentrate for solution for infusion was found to be physically compatible and chemically stable for at least 24 hours when mixed with the following diluents and stored in PVC bags at controlled room temperature 15-25°C.
Diluents: Sodium chloride (0.9%) solution for injection; Lactated Ringer's solution for injection; Dextrose 5% solution for injection.
Medicinal product with particulate matter or discolouration should not be used.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

levetiracetam

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig

Agencia Lei Va Hong